Someone posted this on ihub in 2009.

Swartz is a modern day pirate; Johnson is his right hand man, IMHO!

http://people.forbes.com/profile/carlton-m-johnson/3770

Carlton M. Johnson
Director
Peregrine Pharmaceuticals, Inc.
Tustin , CA
Sector: HEALTHCARE / Biotechnology

Director and Secretary , CryoPort, Incorporated
Lake Forest , CA
Sector: CONSUMER GOODS / Packaging & Containers
Officer since May 2009

Director , Ecotality, Incorporated
Scottsdale , AZ
Sector: UTILITIES / Electric Utilities

Director , Patriot Scientific Corporation
San Diego , CA
Sector: TECHNOLOGY / Communication Equipment

48 Years Old
Mr. Johnson has served as a director since November 1999. Mr. Johnson currently serves as in-house legal counsel for Roswell Capital Partners, LLC and has served as in-house legal counsel for Equiplace Securities, LLC and Swartz Investments, LLC since 1996. Mr. Johnson has been an active member of the Alabama State Bar since 1986, the Florida Bar since 1988, and the State Bar of Georgia since 1997. He has been a shareholder in the Florida AV-rated, Bar-registered firm of Smith, Sauer, DeMaria & Johnson and Vice President and President-Elect of the 600 member Escambia-Santa Rosa Bar Association. He also served on the Florida Bar Young Lawyers Division Board of Governors. Mr. Johnson earned his degree with high honors in History/Political Science at Auburn University and his Juris Doctor, also with high honors, at Samford University - Cumberland School of Law. Mr. Johnson also serves on the board of Patriot Scientific Corporation and CryoPort, Inc., both publicly traded companies.


http://www.secinfo.com/$/SEC/Name.asp?S=eric+s.+swartz&List=S

“Eric S. Swartz”
a.k.a. “Eric S.Swartz”, “s/Eric S. Swartz”
Latest Filing: 9/23/09 as Signatory

--------------------------------------------------------------------------------

As: Registrant
Swartz Eric S

--------------------------------------------------------------------------------

As: Group Member (Non-Registrant Filer: Partner, Affiliate, etc.)
List All Filings as Group Member

Search Recent Filings (as Group Member) for “Eric S. Swartz”
“Eric S. Swartz” has been a Group Member with the following Registrant:
BridgePointe Master Fund/LTD


“Eric S. Swartz” has/had a Group Member interest in the following Registrant:
Ecotality/Inc [ formerly Alchemy Enterprises/LTD ]


“Eric S. Swartz” has been a Group Member with the following 2 Group Members:
Michael C. Kendrick
Roswell Capital Partners/LLC



--------------------------------------------------------------------------------

As: Signatory (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)
List All Filings as Signatory

Search Recent Filings (as Signatory) for “Eric S. Swartz”
“Eric S. Swartz” has been a Signatory for/with the following 40 Registrants:
Accentia Biopharmaceuticals Inc
American Utilicraft Corp
Aquamatrix/Inc [ formerly Nesco Industries Inc ]
Avicena Group/Inc
BPO Management Services [ formerly Research Engineers Inc ]
CHINA HELI RESOURCE RENEWABLE Inc [ formerly China Pharmaceuticals International Corp ]
China Solar & Clean Energy Solutions/Inc [ formerly Deli Solar (USA)/Inc ]
Cordex Pharma/Inc [ formerly Duska Therapeutics/Inc ]
Cryoport/Inc [ formerly Cryoport Systems LLC ]
Delta Petroleum Corp/CO
E Rex Inc
Ea Industries Inc/NJ [ formerly Electronic Associates Inc ]
Ecom Ecom Com Inc [ formerly US Amateur Sports Inc ]
Financialcontent Inc [ formerly Cosmoz Com Inc/CA ]
Findex Com Inc
Guardian Technologies International Inc
Hartcourt Companies Inc
Integral Technologies Inc [ formerly Integral Technologies Inc/CN ]
Itronics Inc
Ivoice/Inc/NJ [ formerly Ivoice/Inc/DE ]
Lincoln Ventures/LLC
Merchantonline Com Inc [ formerly Tarcyn Corp ]
Miracor Diagnostics Inc [ formerly Medical Device Technologies Inc ]
Patriot Scientific Corp
Peregrine Pharmaceuticals Inc [ formerly Techniclone Corp/DE ]
Power Technology Inc/CN
Quikbiz Internet Group Inc [ formerly Nitros Franchise Corp/FL ]
Shopping Com
Solutionsamerica Inc
Studio One Media/Inc [ formerly Dimensional Visions Inc/DE ]
Summedia Com Inc [ formerly Reliance Resources Inc ]
Swartz Private Equity LLC
Tcpi Inc [ formerly Technical Chemicals & Products Inc ]
Thehealthchannel Com Inc [ formerly Innovative Tracking Solutions Corp ]
Torvec Inc
Upside Development Inc [ formerly Alottafun Inc ]
USA Technologies Inc [ formerly USA Entertainment Center Inc ]
Valesc Holdings Inc [ formerly Valesc Inc ]
Waytronx/Inc [ formerly Onscreen Technologies Inc ]
Window Rock Capital Corp [ formerly New Morning Corp ]


“Eric S. Swartz” has/had a Signatory interest in the following Registrant:
Patriot Scientific Corp



Three Amigos:

http://agoracom.com/ir/patriot/forums/discussion/topics/381588-carlton-johnson-eric-swartz-and-david-pohl/messages/1269615

Carlton Johnson, Eric Swartz and David Pohl
posted on Nov 18, 09 06:33PM
are all on the BoD for Peregrine Pharmaceuticals. With all this good news, lately, from Peregrine, I wonder if CJ will be making his exit from PTSC before too long.

TUSTIN, Calif., Nov 18, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that researchers presented positive data on progress in its federally funded preclinical viral hemorrhagic fever (VHF) program, confirming that its phosphatidylserine (PS)-targeting antibodies bind to VHF viruses and virally infected cells and increase survival in a model of lethal VHF infection. The data were presented at the 2009 Chemical and Biological Defense Science and Technology (CBD S&T) Conference in Dallas, Texas.

Researchers presented interim data from Peregrine's multi-year program to assess the company's PS-targeting antibodies as broad-spectrum agents for the treatment of viral hemorrhagic fevers, a potential biodefense threat.

TUSTIN, Calif., Nov 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ --
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHMD) today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures. The study also provides further evidence that the anti-cancer activity of bavituximab and other PS-targeting antibodies reflects multiple novel mechanisms. Bavituximab is currently in Phase II clinical trials for the treatment of advanced breast cancer and advanced lung cancer. The new study is available in the current on-line edition of Clinical Cancer Research(1).

"This important new study provides additional scientific evidence that PS-targeting antibodies, including bavituximab, employ multiple novel mechanisms to mobilize the immune system to combat cancer and that these mechanisms are enhanced by concurrent radiation therapy," said Steven W. King, president and CEO of Peregrine. "The potent anti-tumor effects observed in this study, which used an extremely challenging preclinical model of brain cancer, are very impressive. These results provide a strong rationale for conducting future clinical trials of bavituximab in combination with radiation for the treatment of glioblastoma and other brain cancers."